{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:44:28Z","timestamp":1740109468173,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T00:00:00Z","timestamp":1687824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T00:00:00Z","timestamp":1687824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s00408-023-00629-3","type":"journal-article","created":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T20:19:35Z","timestamp":1687897175000},"page":"381-386","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Relationship Between Serum Angiotensin Converting Enzyme Level and the Decision to Escalate Treatment of Sarcoidosis"],"prefix":"10.1007","volume":"201","author":[{"given":"Boris","family":"Shkolnik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rou","family":"Sore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Salick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gowthami","family":"Kobbari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sana","family":"Ghalib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anoosh S.","family":"Parimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth M.","family":"Fish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Deluca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Recai","family":"Yucel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4663-7985","authenticated-orcid":false,"given":"Marc A.","family":"Judson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,27]]},"reference":[{"issue":"11","key":"629_CR1","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/ni.2107","volume":"12","author":"XZ Shen","year":"2011","unstructured":"Shen XZ, Billet S, Lin C et al (2011) The carboxypeptidase ACE shapes the MHC class I peptide repertoire. Nat Immunol 12(11):1078\u20131085","journal-title":"Nat Immunol"},{"issue":"4","key":"629_CR2","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S0272-5231(05)70416-0","volume":"18","author":"EA Sheffield","year":"1997","unstructured":"Sheffield EA (1997) Pathology of sarcoidosis. Clin Chest Med 18(4):741\u2013754","journal-title":"Clin Chest Med"},{"issue":"4","key":"629_CR3","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/S0272-5231(05)70417-2","volume":"18","author":"JP Lynch 3rd","year":"1997","unstructured":"Lynch JP 3rd, Kazerooni EA, Gay SE (1997) Pulmonary sarcoidosis. Clin Chest Med 18(4):755\u2013785","journal-title":"Clin Chest Med"},{"issue":"11","key":"629_CR4","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1080\/1744666X.2016.1196135","volume":"12","author":"A Chopra","year":"2016","unstructured":"Chopra A, Kalkanis A, Judson MA (2016) Biomarkers in sarcoidosis. Expert Rev Clin Immunol 12(11):1191\u20131208","journal-title":"Expert Rev Clin Immunol"},{"key":"629_CR5","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/j.1749-6632.1986.tb18543.x","volume":"465","author":"R Finkel","year":"1986","unstructured":"Finkel R, Teirstein AS, Levine R, Brown LK, Miller A (1986) Pulmonary function tests, serum angiotensin-converting enzyme levels, and clinical findings as prognostic indicators in sarcoidosis. Ann N Y Acad Sci 465:665\u2013671","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"629_CR6","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","volume":"201","author":"ED Crouser","year":"2020","unstructured":"Crouser ED, Maier LA, Wilson KC et al (2020) Diagnosis and detection of sarcoidosis: an official american thoracic society clinical practice guideline. Am J Respir Crit Care Med 201(8):e26\u2013e51","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"629_CR7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1164\/ajrccm.159.1.9712108","volume":"159","author":"JL Hankinson","year":"1999","unstructured":"Hankinson JL, Odencrantz JR, Fedan KB (1999) Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med 159(1):179\u2013187","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"629_CR8","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1378\/chest.82.6.732","volume":"82","author":"H Klech","year":"1982","unstructured":"Klech H, Kohn H, Kummer F, Mostbeck A (1982) Assessment of activity in sarcoidosis: sensitivity and specificity of 67Gallium scintigraphy, serum ACE levels, chest roentgenography, and blood lymphocyte subpopulations. Chest 82(6):732\u2013738","journal-title":"Chest"},{"issue":"1","key":"629_CR9","first-page":"45","volume":"1","author":"OB Selroos","year":"1984","unstructured":"Selroos OB (1984) Value of biochemical markers in serum for determination of disease activity in sarcoidosis. Sarcoidosis 1(1):45\u201349","journal-title":"Sarcoidosis"},{"issue":"3","key":"629_CR10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3109\/10408368609110273","volume":"24","author":"OB Selroos","year":"1986","unstructured":"Selroos OB (1986) Biochemical markers in sarcoidosis. Crit Rev Clin Lab Sci 24(3):185\u2013216","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"2","key":"629_CR11","first-page":"139","volume":"22","author":"AS Teirstein","year":"2005","unstructured":"Teirstein AS, Judson MA, Baughman RP, Rossman MD, Yeager H Jr, Moller DR (2005) The spectrum of biopsy sites for the diagnosis of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 22(2):139\u2013146","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"2","key":"629_CR12","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.rmed.2014.11.009","volume":"109","author":"AD Vorselaars","year":"2015","unstructured":"Vorselaars AD, van Moorsel CH, Zanen P et al (2015) ACE and sIL-2R correlate with lung function improvement in sarcoidosis during methotrexate therapy. Respir Med 109(2):279\u2013285","journal-title":"Respir Med"},{"issue":"6","key":"629_CR13","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7326\/0003-4819-93-6-825","volume":"93","author":"J Lieberman","year":"1980","unstructured":"Lieberman J, Sastre A (1980) Serum angiotensin-converting enzyme: elevations in diabetes mellitus. Ann Intern Med 93(6):825\u2013826","journal-title":"Ann Intern Med"},{"issue":"3","key":"629_CR14","doi-asserted-by":"publisher","first-page":"361","DOI":"10.7326\/0003-4819-92-3-361","volume":"92","author":"RA DeRemee","year":"1980","unstructured":"DeRemee RA, Rohrbach MS (1980) Serum angiotensin-converting enzyme activity in evaluating the clinical course of sarcoidosis. Ann Intern Med 92(3):361\u2013365","journal-title":"Ann Intern Med"},{"issue":"7","key":"629_CR15","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1136\/thx.40.7.497","volume":"40","author":"RD Cohen","year":"1985","unstructured":"Cohen RD, Bunting PS, Meindok HO, Chamberlain DW, Rebuck AS (1985) Does serum angiotensin converting enzyme reflect intensity of alveolitis in sarcoidosis? Thorax 40(7):497\u2013500","journal-title":"Thorax"},{"issue":"3","key":"629_CR16","first-page":"231","volume":"48","author":"M Rust","year":"1985","unstructured":"Rust M, Bergmann L, Kuhn T et al (1985) Prognostic value of chest radiograph, serum-angiotensin-converting enzyme and T helper cell count in blood and in bronchoalveolar lavage of patients with pulmonary sarcoidosis. Respir Int Rev Thoracic Dis 48(3):231\u2013236","journal-title":"Respir Int Rev Thoracic Dis"},{"issue":"5","key":"629_CR17","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1164\/arrd.1984.129.5.676","volume":"129","author":"RP Baughman","year":"1984","unstructured":"Baughman RP, Fernandez M, Bosken CH, Mantil J, Hurtubise P (1984) Comparison of gallium-67 scanning, bronchoalveolar lavage, and serum angiotensin-converting enzyme levels in pulmonary sarcoidosis: predicting response to therapy. Am Rev Respir Dis 129(5):676\u2013681","journal-title":"Am Rev Respir Dis"},{"issue":"4","key":"629_CR18","first-page":"631","volume":"128","author":"RP Baughman","year":"1983","unstructured":"Baughman RP, Ploysongsang Y, Roberts RD, Srivastava L (1983) Effects of sarcoid and steroids on angiotensin-converting enzyme. Am Rev Respir Dis 128(4):631\u2013633","journal-title":"Am Rev Respir Dis"},{"issue":"5","key":"629_CR19","first-page":"1139","volume":"132","author":"GL Snider","year":"1985","unstructured":"Snider GL (1985) Prediction of therapeutic response in steroid-treated pulmonary sarcoidosis. Am Rev Respir Dis 132(5):1139\u20131140","journal-title":"Am Rev Respir Dis"},{"issue":"1","key":"629_CR20","first-page":"65","volume":"132","author":"WM Hollinger","year":"1985","unstructured":"Hollinger WM, Staton GW Jr, Fajman WA, Gilman MJ, Pine JR, Check IJ (1985) Prediction of therapeutic response in steroid-treated pulmonary sarcoidosis: evaluation of clinical parameters, bronchoalveolar lavage, gallium-67 lung scanning, and serum angiotensin-converting enzyme levels. Am Rev Respir Dis 132(1):65\u201369","journal-title":"Am Rev Respir Dis"},{"issue":"6","key":"629_CR21","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1183\/13993003.04079-2020","volume":"58","author":"RP Baughman","year":"2021","unstructured":"Baughman RP, Valeyre D, Korsten P et al (2021) ERS clinical practice guidelines on treatment of sarcoidosis. Eur Respir J 58(6):158","journal-title":"Eur Respir J"},{"issue":"6","key":"629_CR22","doi-asserted-by":"publisher","first-page":"5282","DOI":"10.1002\/ehf2.13614","volume":"8","author":"Y Kobayashi","year":"2021","unstructured":"Kobayashi Y, Sato T, Nagai T et al (2021) Association of high serum soluble interleukin 2 receptor levels with risk of adverse events in cardiac sarcoidosis. ESC Heart Fail 8(6):5282\u20135292","journal-title":"ESC Heart Fail"},{"issue":"1","key":"629_CR23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12931-019-1263-z","volume":"21","author":"D Bennett","year":"2020","unstructured":"Bennett D, Cameli P, Lanzarone N et al (2020) Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis. Respir Res 21(1):6","journal-title":"Respir Res"},{"key":"629_CR24","doi-asserted-by":"publisher","first-page":"8565423","DOI":"10.1155\/2019\/8565423","volume":"2019","author":"L Bergantini","year":"2019","unstructured":"Bergantini L, Bianchi F, Cameli P et al (2019) Prognostic biomarkers of sarcoidosis: a comparative study of serum chitotriosidase, ACE, lysozyme, and KL-6. Dis Markers 2019:8565423","journal-title":"Dis Markers"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-023-00629-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00408-023-00629-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-023-00629-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T05:01:38Z","timestamp":1692766898000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00408-023-00629-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,27]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["629"],"URL":"https:\/\/doi.org\/10.1007\/s00408-023-00629-3","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"type":"print","value":"0341-2040"},{"type":"electronic","value":"1432-1750"}],"subject":[],"published":{"date-parts":[[2023,6,27]]},"assertion":[{"value":"29 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MAJ: Consultant for Prometheus; Star Therapeutics; has received grants for his institution from Mallinckrodt, aTyr Pharmaceuticals, and Foundation for Sarcoidosis Research. No other author has any competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Albany Medical Center Institutional Review Board (study number 6272).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}